AVITA Medical Inc
RCEL3.620USD
-0.160-4.23%
收盤 11/04, 16:00（美東）報價延遲15分鐘
96.34M總市值
虧損本益比TTM
關於 AVITA Medical Inc 公司
AVITA Medical, Inc. 是一家商業階段再生醫學公司。該公司是再生醫學的提供商，致力於解決燒傷、全層皮膚缺損和白癜風等皮膚色素沉着方面尚未滿足的醫療需求。其 RECELL 平臺是一種一次性、獨立、電池供電的自體細胞採集設備，包含酶和緩衝溶液、無菌手術器械和執行器。RECELL 用於治療熱燒傷傷口和全層皮膚缺損，以及對穩定的脫色白癜風病變進行色素沉着。RECELL 系統的平臺技術能夠處理和製備來自患者的薄層皮膚樣本，產生一種稱爲噴霧皮膚細胞的自體細胞懸浮液。這些噴霧皮膚細胞在護理點只需 30 分鐘即可製備完成，爲治療熱燒傷傷口和全層皮膚缺損提供了一種新方法。
AVITA Medical Inc簡介
公司代碼RCEL
公司名稱AVITA Medical Inc
上市日期Mar 18, 2012
CEOMr. James M. (Jim) Corbett
員工數量260
證券類型Ordinary Share
年結日Mar 18
公司地址28159 Avenue Stanford
城市VALENCIA
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編91355
電話16613679170
網址https://www.avitamedical.com/
公司代碼RCEL
上市日期Mar 18, 2012
CEOMr. James M. (Jim) Corbett
AVITA Medical Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Non-Executive Director
Independent Non-Executive Director
49.63K
+67.49%
Prof. Suzanne Crowe
Prof. Suzanne Crowe
Independent Non-Executive Director
Independent Non-Executive Director
27.71K
--
Mr. Jeremy Curnock Cook
Mr. Jeremy Curnock Cook
Independent Non-Executive Director
Independent Non-Executive Director
20.61K
--
Dr. Michael Tarnoff Tarnoff, M.D.
Dr. Michael Tarnoff Tarnoff, M.D.
Independent Director
Independent Director
--
--
Ms. Jessica Ekeberg
Ms. Jessica Ekeberg
Director - Investor Relations
Director - Investor Relations
--
--
Mr. Cary G. Vance
Mr. Cary G. Vance
Chairman of the Board, Interim Chief Executive Officer
Chairman of the Board, Interim Chief Executive Officer
--
--
Mr. David O'Toole
Mr. David O'Toole
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Jan Stern Reed
Ms. Jan Stern Reed
Non-Executive Lead Independent Director
Non-Executive Lead Independent Director
--
--
Ms. Nicole Linda Kelsey, J.D.
Ms. Nicole Linda Kelsey, J.D.
Chief Legal and Compliance Officer, Corporate Secretary
Chief Legal and Compliance Officer, Corporate Secretary
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Non-Executive Director
Independent Non-Executive Director
49.63K
+67.49%
Prof. Suzanne Crowe
Prof. Suzanne Crowe
Independent Non-Executive Director
Independent Non-Executive Director
27.71K
--
Mr. Jeremy Curnock Cook
Mr. Jeremy Curnock Cook
Independent Non-Executive Director
Independent Non-Executive Director
20.61K
--
Dr. Michael Tarnoff Tarnoff, M.D.
Dr. Michael Tarnoff Tarnoff, M.D.
Independent Director
Independent Director
--
--
Ms. Jessica Ekeberg
Ms. Jessica Ekeberg
Director - Investor Relations
Director - Investor Relations
--
--
Mr. Cary G. Vance
Mr. Cary G. Vance
Chairman of the Board, Interim Chief Executive Officer
Chairman of the Board, Interim Chief Executive Officer
--
--
收入明細
單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
暫無數據
地區USD
名稱
營收
佔比
United States
17.90M
97.17%
Japan
427.00K
2.32%
United Kingdom
55.00K
0.30%
Australia
40.00K
0.22%
European Union (Region)
0.00
0.00%
業務
地區
暫無數據
股東統計
更新時間: 8月17日 週日
更新時間: 8月17日 週日
持股股東
股東類型
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
6.53%
The Vanguard Group, Inc.
5.45%
Geode Capital Management, L.L.C.
2.32%
State Street Investment Management (US)
1.99%
UBS Financial Services, Inc.
1.54%
其他
82.17%
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
6.53%
The Vanguard Group, Inc.
5.45%
Geode Capital Management, L.L.C.
2.32%
State Street Investment Management (US)
1.99%
UBS Financial Services, Inc.
1.54%
其他
82.17%
股東類型
持股股東
佔比
Investment Advisor
16.21%
Investment Advisor/Hedge Fund
7.95%
Hedge Fund
3.40%
Research Firm
1.31%
Individual Investor
0.91%
Pension Fund
0.23%
Venture Capital
0.11%
Bank and Trust
0.10%
Insurance Company
0.03%
其他
69.75%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
206
7.81M
29.34%
-1.85M
2025Q2
210
7.20M
27.22%
-1.82M
2025Q1
225
7.35M
27.79%
-1.89M
2024Q4
218
6.78M
25.72%
-2.16M
2024Q3
215
6.40M
24.41%
-2.52M
2024Q2
210
6.40M
24.65%
-3.74M
2024Q1
216
7.55M
29.29%
-2.27M
2023Q4
213
7.36M
28.65%
-3.81M
2023Q3
208
8.37M
32.77%
-2.77M
2023Q2
206
8.16M
32.08%
-1.08M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
BlackRock Institutional Trust Company, N.A.
1.74M
6.53%
+13.93K
+0.81%
Jun 30, 2025
The Vanguard Group, Inc.
1.45M
5.45%
+16.54K
+1.15%
Jun 30, 2025
Geode Capital Management, L.L.C.
618.34K
2.32%
-1.36K
-0.22%
Jun 30, 2025
State Street Investment Management (US)
528.78K
1.99%
+1.83K
+0.35%
Jun 30, 2025
UBS Financial Services, Inc.
409.80K
1.54%
+65.07K
+18.88%
Jun 30, 2025
Opaleye Management Inc.
389.52K
1.46%
-50.48K
-11.47%
Jun 30, 2025
Millennium Management LLC
369.19K
1.39%
+357.21K
+2980.45%
Jun 30, 2025
Northern Trust Investments, Inc.
242.03K
0.91%
-10.13K
-4.02%
Jun 30, 2025
Jacobs Levy Equity Management, Inc.
138.20K
0.52%
+92.23K
+200.61%
Jun 30, 2025
Wellington Management Company, LLP
110.70K
0.42%
+28.50K
+34.66%
Jun 30, 2025
查看更多
持股ETF
更新時間: 11月2日 週日
更新時間: 11月2日 週日
機構名稱
佔比
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
iShares Micro-Cap ETF
0.01%
iShares Core S&P Total U.S. Stock Market ETF
0%
ProShares UltraPro Russell2000
0%
iShares Russell 3000 ETF
0%
Proshares Ultra Russell 2000
0%
iShares Russell 2000 ETF
0%
iShares Russell 2000 Growth ETF
0%
Global X Russell 2000 ETF
0%
Direxion Daily S&P Biotech Bull 3X Shares
0%
查看更多
Goldman Sachs ActiveBeta US Small Cap Equity ETF
佔比0.03%
iShares Micro-Cap ETF
佔比0.01%
iShares Core S&P Total U.S. Stock Market ETF
佔比0%
ProShares UltraPro Russell2000
佔比0%
iShares Russell 3000 ETF
佔比0%
Proshares Ultra Russell 2000
佔比0%
iShares Russell 2000 ETF
佔比0%
iShares Russell 2000 Growth ETF
佔比0%
Global X Russell 2000 ETF
佔比0%
Direxion Daily S&P Biotech Bull 3X Shares
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
